Separate metabolic and wellness prescription subscriptions

Vytora Health review

Vytora offers separate weight-care, NAD+ and sermorelin subscriptions. I would start by defining which service is needed, then price that agreement; the wider catalogue is not a complete preventive-health programme. NAD+ has a clear three-month total, while other plans contain monthly-label discrepancies worth settling before payment.

A useful next step?

Consider the purpose, the care relationship and the full commitment.

Visit Vytora HealthOfficial provider website. No affiliate relationship is currently listed.

A reason to consider it

Readers comparing one defined remote prescription service with a confirmed preparation, monitoring arrangement and complete bill.

  • Current pages separately identify NAD+, sermorelin and compounded GLP-1 services.
  • Consultation and continuing provider messaging are described.
  • Selected controls state three-month charge totals.

What deserves scrutiny

Buyers seeking comprehensive preventive testing, proven healthy-lifespan gains or one price covering the entire treatment catalogue.

  • Monitoring and full preparation remain service-specific questions.
  • Several monthly figures and shipping policies conflict.
  • A larger catalogue does not establish preventive-care or longevity outcomes.
In this review

Choose the service before judging the catalogue

The current product pages identify NAD+ and sermorelin injections alongside compounded semaglutide and tirzepatide. They establish separate advertised services, not a package of preventive visits, comprehensive tests and all prescriptions. A coming-soon peptide section elsewhere should not erase the specific current product pages or prove additional peptides are available. [1] [2] [3]

NAD+ shows $249 monthly or $600 billed every three months. Its complete formulation, supplied quantity and shipment cadence still need confirmation. The stylized vial is expressly not the actual label or size. I would identify the assigned clinician and dispensing pharmacy before valuing a particular prescription. [2]

A defined follow-up makes a price meaningful

The care page describes physician messaging, a progress portal, supplies and refill delivery. It does not establish a complete included laboratory panel or scheduled preventive review. Ask which assessments and follow-up the proposed service requires, what can be booked and which costs sit outside the plan. [4]

Sermorelin’s panel says $199 monthly while its FAQ says $249; the selected three-month total is $559, with an approximate $186 monthly annotation. Semaglutide and tirzepatide also have monthly-label inconsistencies. Obtain the actual bill and renewal rather than add the smallest displayed figures into an imagined combined programme. [1] [3] [8] [9]

Separate the next renewal from the current sale

Product FAQs say subscriptions charge automatically until cancellation through support. They do not set a precise notice period or establish a prorated refund. Confirm the intended cancellation date and actual order stages, particularly before prepaying three months. [2] [3]

The refund policy says all sales are final and prescription products cannot be returned for reuse or resale. Filling errors have a contact route, without an automatic refund or replacement promise. Neither that policy nor the website terms fully defines the financial result of medical nonapproval or a cancellation before preparation. Obtain those terms before submitting payment. [5] [7]

Do not turn convenience into evidence of longer healthy life

Free-shipping advertising conflicts with policy language about checkout charges. The shipping policy also allows processing and transit delays. Generic warm-shipment stability statements should not replace storage and excursion advice for the actual pharmacy preparation. Service-specific terms qualify nationwide access claims too. [2] [4] [6] [7]

I would compare Vytora for a defined clinical service, rather than a general longevity promise. Compounded medicines are not FDA-approved. A larger menu, convenient messages or reported energy changes do not establish improved healthy lifespan, and evidence for weight treatment cannot simply be transferred to NAD+ or sermorelin. [1] [2] [3] [10]

Understanding the cost

NAD+ $249 monthly/$600 each three months. Sermorelin panel $199 monthly versus FAQ $249; selected three-month total $559. Semaglutide $179 monthly/$447 three-month total with a conflicting monthly label; tirzepatide product $249 monthly/$599 three-month total versus homepage FAQ $199 monthly. Separate services, not a combined package.

Build your cost estimate

Sources

  1. Vytora: catalogue and homepage pricing FAQ
  2. Vytora: NAD+ product and selected monthly/three-month plans
  3. Vytora: sermorelin plans and conflicting monthly FAQ
  4. Vytora: messaging, portal and refill claims
  5. Vytora: complete prescription refund policy
  6. Vytora: processing, delivery and shipping charges
  7. Vytora: platform, clinical entities and eligibility terms
  8. Vytora: semaglutide and selected three-month billing
  9. Vytora: tirzepatide selected plans
  10. FDA: compounded drugs and premarket approval limits

This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.

Affiliate partner

Before you go

Explore this option
Continue to your original choiceWe may earn a commission if you choose our partner. These services may differ in products, fees and clinical access.